Back to Search
Start Over
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac
- Source :
- Barnes, H, Alexander, S, Bower, L, Ehlers, J, Gani, C, Herbert, T, Lawes, R, Møller, P K, Morgan, T, Nowee, M E, Smith, G, van Triest, B, Tyagi, N, Whiteside, L & McNair, H 2021, ' Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac ', Clinical and Translational Radiation Oncology, vol. 30, pp. 31-37 . https://doi.org/10.1016/j.ctro.2021.06.003, Clinical and Translational Radiation Oncology, Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 31-37 (2021), Barnes, H, Alexander, S, Bower, L, Ehlers, J, Gani, C, Herbert, T, Lawes, R, Moller, P K, Morgan, T, Nowee, M, Smith, G, van Triest, B, Tyagi, N, Whiteside, L & McNair, H 2021, ' Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac ', Radiotherapy and Oncology, vol. 161, no. Suppl. 1, PD-0798, pp. S632-S633 . https://doi.org/10.1016/S0167-8140(21)07077-8
- Publication Year :
- 2021
-
Abstract
- Highlights • Questionnaires are important tools in assessing the tolerability of new technology. • Patient reported experience of treatment on the MR-Linac is consistently high. • The MR-Linac questionnaire has been validated as relevant and appropriate for use.<br />Introduction With the implementation of new radiotherapy technology, it is imperative that patient experience is investigated alongside efficacy and outcomes. This paper presents the development of a specifically designed validated questionnaire and a first report of international multi-institutional preliminary patient experience of MRI-guided adaptive radiotherapy (MRgART) on the 1.5 T MR-Linac (MRL). Methods A patient experience questionnaire was developed and validated before being distributed to the Elekta MRL Consortium, to gather first patient-reported experience from participating centres worldwide. The final version of the questionnaire contains 18 questions covering a range of themes and was scored on a Likert scale of 0–3. Responses were post-processed so that a score of 0 represents a negative response and 3 represents the most favourable response. These results were analysed for patient-reported experience of treatment on the MRL. Results were also analysed for internal consistency of the questionnaire using Chronbach’s Alpha and the questionnaire contents were validated for relevance using content validity indexes (CVI). Results 170 responses were received from five centres, representing patients with a wide range of tumour treatment sites from four different countries. MRgART was well tolerated with an 84% favourable response across all questions and respondents. When analysed by theme, all reported the highest percentage of results in the favourable categories (2 and 3). Internal consistency in the questionnaire was high (Cronbach’s α = 0.8) and the item-level CVI for each question was 0.78 or above and the Scale-level CVI was 0.93, representing relevant content. Conclusion The developed questionnaire has been validated as relevant and appropriate for use in reporting experience of patients undergoing treatment on the MRL. The overall patient-reported experience and satisfaction from multiple centres within the Elekta MRL Consortium was consistently high. These results can reinforce user confidence in continuing to expand and develop MRL use in adaptive radiotherapy.
- Subjects :
- Patient experience
medicine.medical_specialty
R895-920
MR Linac
MRI-guided
030218 nuclear medicine & medical imaging
Likert scale
User confidence
03 medical and health sciences
Medical physics. Medical radiology. Nuclear medicine
0302 clinical medicine
Cronbach's alpha
Content validity
Medicine
Radiology, Nuclear Medicine and imaging
Medical physics
Original Research Article
Adaptive radiotherapy
Treatment experience
RC254-282
Mr linac
business.industry
Adaptive Radiotherapy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Oncology
030220 oncology & carcinogenesis
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Barnes, H, Alexander, S, Bower, L, Ehlers, J, Gani, C, Herbert, T, Lawes, R, Møller, P K, Morgan, T, Nowee, M E, Smith, G, van Triest, B, Tyagi, N, Whiteside, L & McNair, H 2021, ' Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac ', Clinical and Translational Radiation Oncology, vol. 30, pp. 31-37 . https://doi.org/10.1016/j.ctro.2021.06.003, Clinical and Translational Radiation Oncology, Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 31-37 (2021), Barnes, H, Alexander, S, Bower, L, Ehlers, J, Gani, C, Herbert, T, Lawes, R, Moller, P K, Morgan, T, Nowee, M, Smith, G, van Triest, B, Tyagi, N, Whiteside, L & McNair, H 2021, ' Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac ', Radiotherapy and Oncology, vol. 161, no. Suppl. 1, PD-0798, pp. S632-S633 . https://doi.org/10.1016/S0167-8140(21)07077-8
- Accession number :
- edsair.doi.dedup.....47b88043206ddcdfabb1b9416326602e